$5.5 Million Awarded to Transvaginal Mesh Patient

$5.5 Million Awarded to Transvaginal Mesh Patient

Posted By The Maher Law Firm || 31-Jul-2012

FDA report found vaginal-mesh to be a “high risk” product for patients.

On July 20th jurors in state court in Bakersfield, California concluded that Christine Scott – a women who received an Avault vaginal mesh implant by Dr. Tillakarasi Kannappan in 2008 – is to be awarded $3.6 million in damages from C.R. Bard Inc (the maker of the vaginal mesh) and $1.9 million from Dr. Tillakarasi Kannappan for medical expenses, pain and suffering.

According to court filings, Dr. Kannappan (who was not a defendant in the trial) is not responsible for paying the $1.9 million in damages.

Scott Lowry, a Bard spokesman, said in an email, “While we empathize with the complications suffered by the plaintiff, those complications are not the fault of any conduct by the company, we believe the evidence establishes that our Avault mesh products, cleared by the FDA, are safe and effective and provide significant benefits to patients.” Bards officials also said, they were disappointed with the jury’s decision to hold the company liable over the implants and would appeal.

U.S. District Judge Joseph R. Goodwin in Charleston, West Virginia, is overseeing consolidated federal suits against pelvic mesh makers, including; Bard, J&J, Boston Scientific Corp. and the American Medical Systems unit of Endo Pharmaceutical Holdings Inc.

If you believe that you or a loved one has suffered injury or death due to a defective or dangerous pharmaceutical, you may have a right to compensation for your injuries. The Maher Law Firm would like to help. We invite you to contact our trial-tested dangerous drug attorneys today.

Blog Home